English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 30 May 2019, 15:16 HKT/SGT
Share:
    

Source: Hitachi, Ltd.
Hitachi Signs Contract with HIMED Xuzhou City, Jiangsu Province, China to Deliver Particle Therapy System

TOKYO, May 30, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE: 6501) has signed a contract with Himed Hospital Management (Xuzhou) Co., Ltd., located in Xuzhou City, Jiangsu Province, People's Republic of China, on May 29 to deliver particle therapy system with capability of irradiating both proton and heavy ion. This is the first order for Hitachi's overseas project of multi ion particle therapy system. With its capability of generating both proton and heavy ion in one accelerator, the system can realize flexible treatment according to various symptom of patients and tumor sites.


The contract signing ceremony


The system will equip one 360-degree rotating gantry room for proton therapy and three fixed beam rooms for carbon therapy, as well as features including real time image gating motion management to irradiate the targeted tumor while in motion and advanced scanning technology to irradiate even tumors with complex shapes with high precision. A treatment planning software, also included in the scope of contract, will utilize imaging data and calculate the appropriate dose to prepare the most suitable, patient-specific treatment plans for each patient. The system will be installed at comprehensive particle therapy center in Xuzhou city, which Himed starts building construction within this year.

The number of site for particle therapy in China is expected to increase in the future, and multiple particle therapy sites are being built in China.

Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities around the world with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients.

Hitachi will continue to accelerate the globalization of its particle therapy system business and contribute to cancer treatment around the world.

Overview of Particle Therapy

Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment.

About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges, combining its operational technology, information technology, and products/systems. The company's consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111


Source: Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501)

Topic: Press release summary
Sectors: BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 
Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd. Releated News
Nov 20, 2019 13:34 HKT/SGT
Mayo Clinic, Hitachi to Build First, Next-Generation, Carbon Ion Therapy Treatment Facility in North America
Nov 20, 2019 12:00 HKT/SGT
米国メイヨー・クリニックと日立が北米初の重粒子線治療システムの納入に関する基本合意書を締結
Nov 19, 2019 14:00 HKT/SGT
「第57回技能五輪全国大会」にて日立グループの選手が金メダル4個を獲得
Nov 19, 2019 12:01 HKT/SGT
Hitachi and Cambridge Renew 30 Year Research Partnership
Nov 18, 2019 11:00 HKT/SGT
日立SEM社がミャンマー連邦共和国 電力・エネルギー省より配電用変圧器約5,600台を受注
More news >>
Copyright © 2019 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575